Ology Bio specializes in R&D (both cGMP and non-cGMP), Process Development, and Manufacturing of vaccines and biologics through commercial stage, with full regulatory support. Our ADM facility accommodates development of bulk drug substance with containment up to BSL-3, which is ideal for vaccine and virus manufacturing. Ology Bio has a proprietary vaccine delivery technology and a variety of platform expression systems available to our clients.
Ology Bio has been highly successful in obtaining US Government contracts and grants (more than $500M to date) for the advanced development and manufacturing of drugs and biologics of importance to both healthcare and national security. Ology Bio works with the DoD, BARDA and NIAID to advance medical countermeasures to protect the American warfighter. We work with technology providers to obtain USG funding and to provide CDMO services to advance their products.